Simplex Trading
OVID icon

Simplex Trading’s Ovid Therapeutics OVID Stock Holding History

Simplex Trading’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.77K Sell
4,400
-46,500
-91% -$83.1K ﹤0.01% 7384
2025
Q4 		$83K Buy
50,900
+47,100
+1,239% +$72.5K ﹤0.01% 5184
2025
Q3 		$4K Buy
+3,800
New +$3.29K ﹤0.01% 8432
2024
Q3 		– Sell
-2,000
Closed -$1K – 9281
2024
Q2 		$1K Sell
2,000
-1,500
-43% -$4.17K ﹤0.01% 8520
2024
Q1 		$10K Buy
3,500
+3,000
+600% +$10K ﹤0.01% 7614
2023
Q4 		$1K Sell
500
-1,200
-71% -$4.1K ﹤0.01% 8550
2023
Q3 		$6K Buy
1,700
+1,000
+143% +$3.6K ﹤0.01% 7556
2023
Q2 		$2K Buy
+700
New +$2.38K ﹤0.01% 8465
2022
Q3 		– Sell
-4,800
Closed -$10K – 10625
2022
Q2 		$10K Buy
4,800
+1,700
+55% +$4.11K ﹤0.01% 8302
2022
Q1 		$9K Sell
3,100
-16,900
-85% -$53.2K ﹤0.01% 8969
2021
Q4 		$64K Sell
20,000
-30,400
-60% -$104K ﹤0.01% 6900
2021
Q3 		$199K Hold
50,400
– – ﹤0.01% 5589
2021
Q2 		$197K Buy
50,400
+50,111
+17,339% +$198K ﹤0.01% 5704
2021
Q1 		$116K Buy
289
+284
+5,680% +$943 ﹤0.01% 5543
2020
Q4 		$1K Sell
5
-90
-95% -$419 ﹤0.01% 8142
2020
Q3 		$54K Sell
95
-138
-59% -$923 ﹤0.01% 5535
2020
Q2 		$171K Buy
+233
New +$1.09K ﹤0.01% 4168

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Simplex Trading's OVID Position: Q1 2026 in Review

Simplex Trading reduced its Ovid Therapeutics (OVID) stake by 88% in Q1 2026, selling an estimated $49.9K and leaving 3,674 shares worth $8.16K. The position accounts for ﹤0.01% of the portfolio, ranked #7524.

Simplex Trading first reported a position in OVID in Q4 2020 and has held it in 11 quarters since. The position peaked at $503K in Q3 2025. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Simplex Trading held 3,674 shares of Ovid Therapeutics worth $8.16K as of Q1 2026.
  • Simplex Trading sold 27,929 Ovid Therapeutics shares in Q1 2026, an estimated $49.9K.
  • Ovid Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7524 holding.
  • Simplex Trading first reported a position in Ovid Therapeutics in Q4 2020 and has held it in 11 quarters since.
  • Simplex Trading's Ovid Therapeutics position peaked at $503K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.